Assignee
HARBIN KANGLONG PHARMACEUTICAL CO LTD
CN·1 granted patent·2 pending applications·0 citations·filing 2022–2025
Top patents by PatentIndex Score
3 records- 0159US12251413B2Use of effective part extract of Monochasma savatieri in preparation of drug for treating inflammatory disease or tumorHARBIN KANGLONG PHARMACEUTICAL CO LTD·Filed 2022·Granted Mar 18, 2025·0 cites·3 claims
- 0256US2025222059A1Use of effective part extract of monochasma savatieri in preparation of drug for treating inflammatory disease or tumorHARBIN KANGLONG PHARMACEUTICAL CO LTD·Filed 2025·Application pending·0 cites
- 0353US2025186530A1Use of effective part extract of monochasma savatieri in preparation of drug for treating inflammatory disease or tumorHARBIN KANGLONG PHARMACEUTICAL CO LTD·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when HARBIN KANGLONG PHARMACEUTICAL CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →